Company Profile
Candel Therapeutics Stock Price, News & Analysis
- Ticker:
- CADL
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Candel Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
9.08 USD (-0.77%)
Close
Last updated: June 23, 2026 at 00:00
665.29M USD
Market cap
Why the stock is moving
CADL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Candel Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Candel Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Candel Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Candel Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Source: Candel Therapeutics
- 02
- 03
- 04
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Source: Candel Therapeutics
- 05
Candel Therapeutics to Present at Upcoming Investor Conferences
Source: Candel Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Candel Therapeutics (CADL)?
Candel Therapeutics (CADL) most recently closed at 9.08 USD, a -0.77% move versus the previous session.
What is the market cap of Candel Therapeutics (CADL)?
Candel Therapeutics currently has a market capitalization of 665.29M USD on BioPharmSignal.
What does Candel Therapeutics do?
Candel Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is CADL stock listed?
Candel Therapeutics (CADL) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Candel Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Candel?
Candel Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Candel Therapeutics targeting with Candel?
Candel Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Candel Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.